Doxycycline Delayed-Release Tablets Suppliers & Bulk Manufacturers
Available Forms: Doxycycline Delayed-Release Tablets
Available Strengths: 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 150 mg, 200 mg.5 Feb 2025
Reference Brands: Vibramycin (US & EU)
Category: Antibiotics
Doxycycline delayed-release tablets and capsules inhibit bacterial protein synthesis by binding to the 30S ribosomal subunit, preventing aminoacyl-tRNA attachment. They provide sustained, effective antimicrobial action with fewer gastrointestinal side effects, making them suitable for long-term treatment of respiratory, urinary, and skin infections, with benefits including improved compliance and consistent drug levels. Doxycycline Delayed-Release Tablets is available in Doxycycline Delayed-Release Tablets and strengths such as 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 150 mg, 200 mg.5 Feb 2025. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Doxycycline Delayed-Release Tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Doxycycline Delayed-Release Tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description: Doxycycline delayed-release tablets and capsules are approved in the EU and US for treating respiratory, urinary, and skin infections. In the EU, brands like Vibramycin XR are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data, with generics widely available. Both regions require detailed dossiers, including clinical trial results, quality assurance, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert assistance with regulatory dossiers, compliance, and registration, visit PharmaTradz. We facilitate seamless market access for doxycycline XR formulations, ensuring adherence to European and US standards for safe, effective antibiotic therapy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Minocycline Hydrochloride
Strength:
50 mg, 75 mg, 100 mg, 20 mg/m
Form: Tablets/ capsules/ Injectable
Reference Brands: Minocin (USA), Solodyn (USA)
View DetailsTetracycline Hydrochloride
Strength:
250 mg, 500 mg
Form: Tablets, Capsules
Reference Brands: Achromycin (USA)
View DetailsOmadacycline
Strength:
100 mg, 150 mg
Form: Tablet/ Injection
Reference Brands: Nuzyra (USA/EU)
View DetailsNitrofurantoin
Strength:
25 mg, 50 mg, 100 mg
Form: Capsules
Reference Brands: Macrobid (USA), Macrodantin (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers